¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sequence analysis, RNA"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • arterial blood gas analysis
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®, ¹æ»çÈ­ºÐ¼®
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • analysis
    ºÐ¼®
  • birth cohort analysis
    Ãâ»ýÄÚȣƮºÐ¼®
  • clinical decision analysis
    ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
  • clonal analysis
    Ŭ·ÐºÐ¼®
  • cluster analysis
    ¹«¸®ºÐ¼®
  • cohort analysis
    ÄÚȣƮºÐ¼®
  • computer-assisted semen analysis
    ÄÄÇ»ÅÍÁ¤¾×°Ë»ç
  • computerized image analysis
    ÄÄÇ»ÅÍ¿µ»óºÐ¼®
  • control analysis
    ÁöµµºÐ¼®
  • cost-benefit analysis
    ºñ¿ëÆíÀͺм®
  • cost-effectiveness analysis
    ºñ¿ëÈ¿°úºÐ¼®
  • cost-efficiency analysis
    ºñ¿ëÈ¿À²ºÐ¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • reaction sequence
    ¹ÝÀÀ¼ø¼­
  • respiratory sequence
    È£Èí¼ø¼­
  • sequence
    ¼ø¼­, ¿¬¼â
  • signal sequence
    ½ÅÈ£¼ø¼­
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • ultra fast sequence
    Ãʰí¼Ó¿¬¼â
  • analysis
    ºÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®, ¹æ»çÈ­ºÐ¼®
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • antigen analysis
    Ç׿øºÐ¼®
  • birth cohort analysis
    Ãâ»ýÄÚȣƮºÐ¼®
  • case analysis
    Áõ·ÊºÐ¼®
  • clinical decision analysis
    ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
  • clonal analysis
    Ŭ·ÐºÐ¼®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • RNA=£¾ribonucleic acid
    ¸®º¸ÇÙ»ê.
  • hybridization, DNA-RNA
    DNA-RNA ¦Áö¿ì±â, DNA-RNA ºÎÇÕÈ­(~ݬùêûù)
  • immunogen RNA
    ¸é¿ª¿ø¼º RNA.
  • positive strand RNA
    ¾ç¼º°¡´Ú RNA
  • pseudoknot RNA structure
    ¸ÅµìÇü RNA ±¸Á¶
  • Data analysis
    Á¤º¸ºÐ¼®
  • Decision analysis
    °áÁ¤ºÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®(¡­ÝÂà°), ¹æ»çÈ­(Û¯ÞÒûù)ºÐ¼®.
  • activation analysis
    ¹æ»çÈ­ºÐ¼®, Ȱ¼ºÈ­ºÐ¼®
  • amniotic fluid analysis
    ¾ç¼öºÐ¼®
  • analysis
    ºÐ¼®
  • analysis of variance technique
    ºÐ»ê±â¼úºÐ¼®
  • analysis, antigen
    Ç׿øºÐ¼®
  • frequency analysis
    Á֯ļöºÐ¼®
  • gas analysis
    °¡½ººÐ¼®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gradient echo (GRE) pulse sequence
    °æ»ç ¿¡ÄÚ ÆÞ½º ¿¬¼â
  • gradient echo sequence
    °æ»ç ¿¡ÄÚ ¿¬¼â
  • imaging of STIR sequence
    STIR ¿¬¼â ¿µ»ó
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • insertion sequence, IS
    »ðÀÔ¼­¿­, »ðÀÔ¿ä¼Ò
  • intervening sequence (intron)
    ÀÎÆ®·Ð, Àü±¸À¯ÀüÀÚ Çã¼­¿­
  • inversion recovery pulse sequence
    ¿ªÀü ȸº¹ ÆÞ½º ¿¬¼â
  • mixed sequence
    º¹ÇÕ ¿¬¼â
  • multislice FLASH sequence
    ´ÙÀýÆí FLASH ¿¬¼â
  • oligohydroamnios sequence
    ¾ç¼ö°ú¼Ò¿¬¼â(åÏâ©Î¦á³ææáð)
  • packaging sequence
    ²Ù¸®±â¼­¿­
  • partial saturation spin echo sequence
    ºÎºÐ Æ÷È­ ½ºÇÉ ¿¡ÄÚ ¿¬¼â
  • partial sequence
    ºÎºÐ¼­¿­.
  • porters sequence
    Æ÷ÅÍ¿¬¼â(¡­ææáð), Æ÷Å͹迭¼ø(¡­ÛÕÖªâ÷)
  • pulse sequence
    ¹Úµ¿ ¿¬¼â, ÆÞ½º ¿¬¼â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • waterfall sequence
    ÆøÆ÷ ¼­¿­ (øîøÖßíÖª)
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼® (üÀàõûùÝÂà°)
  • amino acid analysis
    ¾Æ¹Ì³ë»ê(ß«) ºÐ¼®(ÝÂà°)
  • analysis of variance
    ºÐ»êºÐ¼®(ÝÂߤÝÂà°)
  • conformational analysis
    ÀÔüÇüÅ ºÐ¼®(Ø¡ô÷û¡÷¾ÝÂà°)
  • control analysis
    ´ëÁ¶ ºÐ¼®(ÓßðÎÝÂà°)
  • covalent structure analysis
    °øÀ¯°áÇÕ ±¸Á¶ºÐ¼®(ÍìêóÌ¿ùêϰðãÝÂà°)
  • differential thermal analysis
    Â÷ ¿­ºÐ¼®(ó¬æðÝÂà°)
  • displacement analysis
    ´ëÄ¡ºÐ¼®(ÓÛöÇÝÂà°)
  • double isotope dilution analysis
    ÀÌÁß µ¿À§¿ø¼Ò Èñ¼®ºÐ¼®(ì£ñìÔÒêÈêªáÈýüà·ÝÂà°)
  • elementary analysis
    ¿ø¼Ò ºÐ¼® (êªáÈÝÂà°)
  • elution analysis
    ¿ë¸® ºÐ¼® (éÁ×îÝÂà°)
  • end-group analysis
    Á¾´Ü±â ºÐ¼® (ðûÓ®ÐñÝÂà°)
  • fluctuation analysis
    ¿äµ¿ ºÐ¼®(èôÔÑÝÂà°)
  • gravimetric analysis
    ¹«°Ô ºÐ¼®(ÝÂà°)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • RF pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • sequence
    ¿¬¼â, ¹è¿­¼ø(¼­)
  • sequence
    ¿¬¼â, ¿¬¼Ó
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • ultra fast sequence
    Ãʰí¼Ó¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MRA magnetic resonance angiography; main renal artery; marrow repopulation activity; medical record anal...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MSP Minute Sequence Pyelogram
RSP Rapid Sequence IVP
aa seq amino acid sequence
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
EST Expressed Sequence Tag
EGS External Guide Sequence
ICSBP IFN consensus sequence binding protein
IS Insertion Sequence
ICSBP Interferon consensus sequence binding protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • infrared spectroscopic analysis
    Àû¿Ü¼± ºÐ±¤ ºÐ¼®
  • inorganic analysis
    ¹«±â ºÐ¼®
  • laboratory analysis
    ½ÇÇè½Ç ºÐ¼®
  • mixed dentition analysis
    È¥ÇÕ Ä¡¿­±âÀÇ ¾Ç±Ã °ø°£ ºÐ¼®
    È¥ÇÕ Ä¡¿­±â ±³ÇÕÀº ¿µ±¸ Á¦1 ´ë±¸Ä¡°¡ ¸ÍÃâÇÏ´Â 6-7¼¼ºÎÅÍ Çü¼ºµÈ´Ù. ½ÃÁø ¹× ±¸°­ ¹æ»ç¼±ÇÐÀû °Ë»çÀÇ È°¿ëÀ» ÅëÇØ ¿µ±¸Ä¡ ¸ÍÃâ ¼ø¼­¸¦ »ìÆìº¸´Â °ÍÀº Á¤»ó ±³ÇÕ Çü¼ºÀÇ °¡´É¼º ÆÇ´Ü¿¡ À¯È¿ÇÑ Á¤º¸¸¦ Á¦°øÇØ ÁØ´Ù.
  • occlusal analysis
    ±³ÇÕ ºÐ¼®
    ±³Çձ⿡ ÀåÂøµÈ ¸ðÇüÀÇ ±³ÇÕ °ü°è¸¦ Æò°¡ÇÏ´Â ±³ÇÕ.
  • qualitative analysis
    Á¤¼º ºÐ¼®
    È­ÇÐ ºÐ¼®¹ý Áß¿¡¼­ ½Ã·á°¡ ¾î¶² ¼ººÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´ÂÁö ¾Ë¾Æ³»±â À§ÇÑ ºÐ¼®¹ýÀÇ ÃÑĪ. ÀϹÝÀûÀ¸·Î Á¤·® ºÐ¼®À» Çϱâ Àü¿¡ Á¤¼º ºÐ¼®À» ÇÏ°Ô µÈ´Ù. ¹°ÁúÀ» ±¸¼ºÇϰí ÀÖ´Â È­ÇÐÁ¾
  • script analysis
    °¢º» ºÐ¼®
    »çȸ¿¡ Âü¿©ÇÒ ¶§ Çൿ ¾ç»óÀÇ Æ²ÀÎ °¢º»ÀÌ ¸¸µé¾îÁö´Â °úÁ¤¿¡ ´ëÇÑ ºÐ¼®.
  • sequential analysis
    ¼øÂ÷Àû ºÐ¼®
  • single-factor versus multiple-factor analysis
    ´ÜÀÏ ¿ä¼Ò ºÐ¼® ´ë º¹ÇÕ ¿ä¼Ò ºÐ¼®
  • space analysis
    °ø°£ ºÐ¼®
  • spectral analysis
    ½ºÆåÆ®·³ ºÐ¼®
    ¹°ÁúÀÇ ¹æÃâ ½ºÆåÆ®·³ ¶Ç´Â Èí¼ö ½ºÆåÆ®·³À» Á¶»çÇÏ¿©, ±× ¼Ó¿¡ ÀÖ´Â ¼ººÐ ¿ø¼Ò³ª È­ÇÕ¹°ÀÇ Á¾·ù¿Í ¾çÀ» ÆÇÁ¤ÇÏ´Â ¹æ¹ý. ºÐ±¤ È­ÇÐ ºÐ¼®À̶ó°íµµ ÇÑ´Ù. 19¼¼±â Áß¿±¿¡ R. ºÐÁ¨ÀÌ G. ۸£È÷È£ÇÁÀÇ Çù·ÂÀ» ¾ò¾î È®¸³½ÃŲ ½ÇÇè ±â¼úÀ̸ç, º¸ÅëÀÇ È­ÇÐ ºÐ¼®¿¡ ºñÇÏ¿© Á¶ÀÛÀÌ ºü¸£°í, ¼Ò·®ÀÇ ½Ã·á·Îµµ ºÐ¼®ÀÌ °¡´ÉÇÑ ÀÌÁ¡ÀÌ ÀÖ´Ù. ¹æÃâ ½ºÆåÆ®·³¿¡ ÀÇÇÑ °Í°ú, Èí¼ö ½ºÆåÆ®·³¿¡ ÀÇÇÑ °ÍÀÇ µÎ °¡Áö·Î Å©°Ô ³ª´­ ¼ö ÀÖ´Ù. ¡¼¹æÃâ ½ºÆåÆ®·³¿¡ ÀÇÇÑ ºÐ¼®¡½ ¿øÀÚ¿¡¼­ ¹æÃâµÇ´Â ºûÀÇ ½ºÆåÆ®·³ÀÌ °¢ ¿ø¼Ò¿¡ µû¶ó °íÀ¯ÇÔÀ» ÀÌ¿ëÇÔÀ¸·Î½á, ½Ã·á¸¦ ¹ß±¤½ÃÄÑ ½ºÆåÆ®·³À» °Ë»çÇϰí, ¹Ì¸® Á¶»çÇÏ¿© µÐ Ç¥ÁØ ½Ã·áÀÇ ¹æÃâ ½ºÆåÆ®·³À» ±âÃÊ·Î ¼ººÐ ¿ø¼ÒÀÇ Á¾·ù³ª ¾çÀ» ¾Ë¾Æ³»´Â ¹æ¹ýÀÌ´Ù. °ËÃâÀÇ Á¤¹Ðµµ´Â ¿ø¼Ò¿¡ µû¶ó ´Ù¸£Áö¸¸, ÀϹÝÀûÀ¸·Î È­ÇÐ ºÐ¼®¿¡ ºñÇÏ¿© °¨µµ°¡ ³ô°í, ƯÈ÷ ±Ý¼Ó¿¡ ¹Ì·®À¸·Î ÇÔÀ¯µÇ¾î ÀÖ´Â ºÒ¼ø¹° ¿ø¼ÒÀÇ ¹ß°ßÀ̳ª Á¤·® µî¿¡´Â ÁÁÀº °á°ú¸¦ ¾òÀ» ¼ö ÀÖ´Ù. ½Ã·á¸¦ ¹ß±¤½ÃŰ´Â µ¥´Â º¸Åë ½Ã·á¸¦ ÇÑÂÊ ±ØÀ¸·Î ÇÏ´Â ¾ÆÅ© ¹æÀüÀ̳ª, ±âü »óÅÂÀÇ ½Ã·á¸¦ ¹æÀü°ü¿¡ ä¿ö¼­ ¹æÀü½ÃŰ´Â ¹æ¹ýÀÌ ÀÌ¿ëµÈ´Ù. ¾ËÄ®¸® ±Ý¼ÓÀ̳ª ¾ËÄ®¸®Åä ±Ý¼Ó¿¡ ´ëÇÑ ºÒ²É ¹ÝÀÀÀ» ÀÌ¿ëÇÑ ºÒ²É ½ÃÇèµµ ¹æÃâ ½ºÆåÆ®·³¿¡ ÀÇÇÑ °£´ÜÇÑ ºÐ±¤ ºÐ¼®À̶ó ÇÒ ¼ö ÀÖ´Ù. ¡¼Èí¼ö ½ºÆåÆ®·³¿¡ ÀÇÇÑ ºÐ¼®¡½ ±âü³ª ¿ë¾×¿¡ ¿¬¼Ó ½ºÆåÆ®·³À» °¡Áø ºûÀ» Á¶»çÇϸé, ±× ¼Ó¿¡ Á¸ÀçÇϴ Ȭ ¿ø¼ÒÁúÀ̳ª È­ÇÕ¹°ÀÌ °¢°¢ ƯÀ¯ÇÑ ÆÄÀåÀÇ ºûÀ» ¼±ÅÃÀûÀ¸·Î Èí¼öÇϹǷÎ, Åõ°ú±¤ÀÇ ½ºÆåÆ®·³¿¡´Â ¹°ÁúÀÇ Á¾·ù¿¡ µû¶ó ƯÀ¯ÇÑ ¹è¿­À» °¡Áø Èí¼ö ¼±ÀÌ ³ªÅ¸³­´Ù. µû¶ó¼­, ¾î¶² ¾ç ¶Ç´Â µÎ²²ÀÇ ¼ø¼öÇÑ ¹°ÁúÀÇ Èí¼ö ½ºÆåÆ®·³À» ¸¹ÀÌ °®Ãß°í ÀÖÀ¸¸é, À̰ÍÀ» ±âÃÊ·Î ÇÏ¿© ¹ÌÁö ½Ã·áÀÇ Á¤¼º ºÐ¼®, ¾Ë°í ÀÖ´Â ½Ã·áÀÇ Á¤·® ºÐ¼®, ½Ã·á ¼Ó¿¡ ÀÖ´Â ºÒ¼ø¹°ÀÇ ¹ß°ß ¹× Á¤·®ÇÒ ¼ö ÀÖ´Ù. À̰ÍÀÌ Èí¼ö ½ºÆåÆ®·³¿¡ ÀÇÇÑ ºÐ±¤ ºÐ¼®À̸ç, ƯÈ÷ ¿ë¾× ¼Ó¿¡ Á¸ÀçÇÏ´Â ºñŸ¹Î·ùÀÇ Á¤·® µîÀº ÀÌ ¹æ¹ýÀ» »ç¿ëÇÏ¸é ½±°Ô ¾Ë ¼ö ÀÖ´Ù. ºÐ±¤ ºÐ¼®Àº ½ºÆåÆ®·³ ºÐ¼®À̶ó°íµµ Çϴµ¥, ½ºÆåÆ®·³ ºÐ¼®À̶ó°í ÇÒ ¶§´Â ÀÌ»ó°ú °°Àº ºÐ¼® È­Çп¡ÀÇ ÀÀ¿ë ¿Ü¿¡, ¹°ÁúÀÇ ¹æÃâ ¶Ç´Â Èí¼ö ½ºÆåÆ®·³À» Á¤¹ÐÈ÷ ÃøÁ¤, ÇØ¼®ÇÏ¿© ¹°ÁúÀÇ ¿¡³ÊÁö ÁØÀ§, ÀüÀÌ È®·ü, ºÐÀÚÀÇ °áÇÕ °£°ÝÀ̳ª ºÐÀÚ ±¸Á¶ÀÇ °áÁ¤ µî¿¡µµ ÀÌ¿ëµÈ´Ù.
  • spectrophotometric analysis
    ºÐ±¤ ±¤µµ ºÐ¼®
  • statistic :

    statistical analysis

    Åë°èÀû ºÐ¼®
  • stress analysis
    ÀÀ·Â ºÐ¼®
  • synovial fluid analysis
    Ȱ¾× ºÐ¼®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
sequence hypothesis Francis Crick's seminal concept that genetic information exists as alinear DNA code, DNA and protein sequence are colinear.
(09 Oct 1997)
sequence ladder The array of bands, made conspicuous by labeling, when DNA fragmented by endonucleases is subject to gel electrophoresis; corresponds to the nucleotide sequence.
(05 Mar 2000)
sequence pulse In magnetic resonance imaging, the series of radiofrequency signals used to shift the magnetic field to change proton orientation.
(05 Mar 2000)
sequence, regulatory A sequence of bases in DNA that controls the expression of a gene.
(12 Dec 1998)
sequence tagged site <molecular biology> Short (200 to 500 base pairs) DNA sequence that has a single occurrence in the human genome and whose location and base sequence are known.
Detectable by PCR, sequence tagged sites are useful for localising and orienting the mapping and sequence data reported from many different laboratories and serve as landmarks on the developing physical map of the human genome.
Expressed sequence tags are sequence tagged sites derived from cDNAs.
(11 Jun 1998)
sequence-tagged site map A map representing the order and spacing of sequence-tagged sites within a stretch of DNA.
(05 Mar 2000)
sequence tagged sites Short, tagged tracts of DNA sequence that are used as landmarks in genome mapping. In most instances, 200 to 500 base pairs of sequence define a sequence tagged site (sts) that is operationally unique in the human genome (i.e., can be specifically detected by the polymerase chain reaction in the presence of all other genomic sequences). The overwhelming advantage of stss over mapping landmarks defined in other ways is that the means of testing for the presence of a particular sts can be completely described as information in a database.
(12 Dec 1998)
sequence-tagged sites Short stretches of DNA sequences that can be detected by use of the polymerase chain reaction.
(05 Mar 2000)
pyrimidine-guanine sequence-specific ribonuclease <enzyme> From yolk granules of adult rana catesbeiana oocytes
Registry number: EC 3.1.27.-
Synonym: rc-rnase, rana catesbeiana rnase
(26 Jun 1999)
shine-dalgarno sequence A short stretch of nucleotides on a prokaryotic mRNA molecule upstream of the translational start site, that serves to bind to ribosomal RNA and thereby bring the ribosome to the initiation codon on the mRNA.
(09 Oct 1997)
signal sequence A peptide present on proteins that are destined either to be secreted or to be membrane components. It is usually at the N terminus and normally absent from the mature protein. Normally refers to the sequence (ca 20 amino acids) that interacts with signal recognition particle and directs the ribosome to the endoplasmic reticulum where co translational insertion takes place. Could also refer to sequences that direct post translational uptake by organelles. Signal peptides are highly hydrophobic but with some positively charged residues. The signal sequence is normally removed from the growing peptide chain by signal peptidase, a specific protease located on the cisternal face of the endoplasmic reticulum.
See: signal recognition particle.
(18 Nov 1997)
signature sequence Short oligonucleotides of unique sequence found in 16S ribosomal RNA of a particular group of prokaryotes.
(09 Oct 1997)
disruption sequence The events that occur when a foetus that is developing normally is subjected to a destructive agent such as the rubella (German measles) virus.
(12 Dec 1998)
DNA sequence <molecular biology> The relative order of base pairs, whether in a fragment of DNA, a gene, a chromosome, or an entire genome.
See: base sequence analysis.
(09 Oct 1997)
DNA sequence, unstable DNA region comprised of a variable number of repetitive, contiguous trinucleotide sequences. Presence of these regions is associated with diseases such as fragile x syndrome and myotonia atrophica.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • systems analysis
    (´É·ü,Á¤¹Ðµµ¸¦ ³ôÀ̱â À§ÇÑ) ½Ã½ºÅÛ ºÐ¼®
  • ultimate analysis
    ¿ø¼Ò ºÐ¼®
  • ultimate analysis
    ¿ø¼Ò ºÐ¼®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á